id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2333934,30e5c865-13a6-4dbf-8374-67b6ac344256,Q3,THE CONSILIO GROUP,400374717,"MADEN TECH CONSULTING, INC.",2019,third_quarter,MED,Infrastructure rebuilding.,"Federal Emergency Management Agency (FEMA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE",6000,,0,0,2019-07-25T09:46:25.487000-04:00
2337160,b7427d2b-2728-4df6-9fce-edc93cc621cd,Q3,MAGNET STRATEGY GROUP,401104125,MEDICAGO INC.,2019,third_quarter,MED,"Strategies for emergency heath response, with respect to development and deployment of medical countermeasures for emerging infectious disease.","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2019-09-20T10:38:26.867000-04:00
2337180,71bdf79d-8f59-448d-a212-664cbc033cae,3T,"TCH GROUP, LLC",51478,INTERNATIONAL AIDS VACCINE INITIATIVE,2019,third_quarter,MED,"FY 20 State Foreign Operations Subcommittee Appropriations bills (including HR 2740 and HR 2839). Specifically, continued Federal funding under USAID for AIDS vaccine research and development.","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,1,2019-09-23T15:37:36.670000-04:00
2337337,83c39bda-e65a-4124-8be8-92db8772884d,Q3,AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY,3344,AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY,2019,third_quarter,MED,Appropriations / budget,"Energy, Dept of,HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE",50000,,0,0,2019-09-26T11:16:51.957000-04:00
2337388,6352b357-dd20-40eb-a438-3037693c76b8,Q3,JUSTICE FOR JAKE,401104713,JUSTICE FOR JAKE,2019,third_quarter,MED,"Single photon emission computed tomography, substance use disorder, overdose fatalities, neonatal abstinence syndrome.",White House Office,,,0,0,2019-09-28T10:07:05.577000-04:00
2337613,c829866f-9f68-4c6a-8323-9515b56842cd,Q3,"FRANCIS EDWARD & CRONIN, INC.",311314,"PATH DECISION SUPPORT SOFTWARE, LLC",2019,third_quarter,MED,Issues and legislation related to diabetes treatment and diagnosis,"Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,,0,0,2019-10-01T11:38:15.357000-04:00
2337619,25ab5b62-fd47-4aad-b267-b83ee0b3a2e7,Q3,"FRANCIS EDWARD & CRONIN, INC.",311314,CURE ALZHEIMER'S FUND,2019,third_quarter,MED,Issues and legislation related to Alzheimer's disease research,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE",20000,,0,0,2019-10-01T11:40:19.547000-04:00
2337681,eae155b9-2ed0-4c4c-aae1-e6685b037df8,Q3,VAN FLEET ASSOCIATES,39781,ESTHETIC EDUCATION,2019,third_quarter,MED,Seeking approval from the FDA as an approved medical device,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2019-10-01T14:19:59.567000-04:00
2337912,093d5b0c-a3fe-41f8-b4f4-562ed8cc1c1b,Q3,"RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)",400361684,PPLA,2019,third_quarter,MED,Pharmaceutical labeling,Food & Drug Administration (FDA),18700,,0,0,2019-10-02T09:56:59.687000-04:00
2337918,9297e66e-eb69-45df-a2c1-d3c66673a028,Q3,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2019,third_quarter,MED,Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,144981,0,0,2019-10-02T10:28:01.477000-04:00
2338115,b9a597dd-10f3-4a3b-84f9-07754377518b,Q3,MARSHALL BRACHMAN,6848,BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM,2019,third_quarter,MED,support funding for medical research programs,"HOUSE OF REPRESENTATIVES,SENATE",33000,,0,0,2019-10-03T09:25:10.797000-04:00
2338157,cf6271fe-e19f-4ad1-bf1d-2ec376aacdeb,Q3,WAKE FOREST UNIVERSITY HEALTH SCIENCES,6781,WAKE FOREST UNIVERSITY HEALTH SCIENCES,2019,third_quarter,MED,Higher Education Act reauthorization; animal research legislation; FY 2020; Departments of Labor/HHS appropriations bill;,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,150000,0,0,2019-10-03T11:07:30.787000-04:00
2338359,97aaece5-88f8-4a10-8df0-ec2093c19071,Q3,NATURAL RESOURCE RESULTS LLC,321555,SHINE MEDICAL TECHNOLOGIES,2019,third_quarter,MED,Support budget and approps for grants to cooperatives on medical isotope MO-99 production facility.,"Energy, Dept of,HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",10000,,0,0,2019-10-03T20:02:41.907000-04:00
2338369,52f1be1a-5098-4492-8474-4e9b13188b82,3T,"THE PETRIZZO GROUP, INC.",305932,"UNITED BIOMEDICAL, INC.",2019,third_quarter,MED,"Advocated for federal funding and development of robust vaccine research for Alzheimer's, Parkinson's and other neurological diseases.","Agriculture, Dept of (USDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institute of Mental Health (NIMH),Natl Institutes of Health (NIH),SENATE,White House Office",,,0,1,2019-10-03T20:47:51.337000-04:00
2338508,5dadda44-f586-4005-af93-c16e1b37c595,Q3,"AUBURN HEALTH STRATEGIES, LLC",292697,"NEUROTECH, LLC",2019,third_quarter,MED,EEG monitoring,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2019-10-04T11:29:27.097000-04:00
2339095,05c7f1d7-6a74-48ee-aa20-421f415bad07,Q3,HOLLAND & KNIGHT LLP,18466,PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION,2019,third_quarter,MED,"Over the counter drug approval process for sunscreen ingredients; Implementation of Public Law 113-195, the Sunscreen Innovation Act; House and Senate FY 2020 Ag-FDA Appropriations bills and reports (H.R. 3164 & S.2522); Sunscreen use in schools; Sunscreen provisions in H.R. 3443, Over-the-Counter Monograph Safety, Innovation and Reform Act of 2019; Issues related to state bans on sunscreen ingredients.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",70000,,0,0,2019-10-07T16:09:04.100000-04:00
2339216,e6542e6e-362a-46df-892a-c6536d33ddaf,Q3,"REPUBLIC CONSULTING, LLC",401016871,IQVIA,2019,third_quarter,MED,Monitor Data and Science policy.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2019-10-08T10:44:17.160000-04:00
2339339,e13aae7c-f2cd-4884-a5c6-4198fe58c72f,3T,THE CONSILIO GROUP,400374717,"MADEN TECH CONSULTING, INC.",2019,third_quarter,MED,Infrastructure rebuilding.,"Federal Emergency Management Agency (FEMA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE",6000,,0,1,2019-10-08T13:26:02.880000-04:00
2339353,096e58a0-eabb-4772-bbf3-fc6f822c65ad,Q3,MICHAEL N. MCCARTY LAW OFFICE PLLC,401104300,AMERICAN MEDICAL TECHNOLOGISTS,2019,third_quarter,MED,"Appropriations for harmonization of diagnostic laboratory test results; Appropriations for CDC initiative to establish pediatric reference intervals for clinical diagnostic testing; proposed legislation to establish clinical laboratory workforce development initiatives under the Public Health Service Act and other potential legislative vehicles; prospective legislation to regulate in vitro clinical diagnostic tests, including laboratory-developed tests.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2019-10-08T13:40:11.257000-04:00
2339587,71c8b720-5252-4850-806f-fea1d1abc7d0,Q3,"MANATT, PHELPS, AND PHILLIPS",23645,"SCIENCE CARE, INC.",2019,third_quarter,MED,H.R. 1835 Consensual Donation and Research Integrity Act of 2019,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2019-10-09T11:10:46.707000-04:00
2339616,b65012d4-2dfe-42f8-a17a-fd23e02cad7f,Q3,"THE CJR GROUP, INC.",288293,UNIVERSITY HOSPITALS HEALTH SYSTEM,2019,third_quarter,MED,"NIH funding, mental health initiatives","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2019-10-09T11:35:00.047000-04:00
2339831,11f1ac00-c940-493f-accd-c15bcb648db0,Q3,CHRISTOPHERSEN INC,401105404,WASHINGTON CANNABUSINESS ASSOCIATION,2019,third_quarter,MED,"Safe Banking Act, HR1595

cannabis, manufacturing, economic development, consumer issues product safety, food industry/safety/labeling, medical/disease research/clinical labs, small business, agricluture","Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2019-10-09T15:15:07.687000-04:00
2339990,f04994b6-ad70-4e87-ac51-76050bd485bc,Q3,OTT BIELITZKI & O'NEILL PLLC,401103584,BIOPORTO DIAGNOSTICS A/S,2019,third_quarter,MED,Educating officials about a health care diagnostic tool.,"Agriculture, Dept of (USDA),Defense, Dept of (DOD),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2019-10-10T16:04:33.097000-04:00
2340009,4df7fbe2-8d83-4d81-a7b4-4ba38aff6664,Q3,CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER,312496,CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER,2019,third_quarter,MED,"NIH Budget, PCORI re authorization, NICHD budget, sickle cell research, CHGME, 340B, surprise billing legislation, screening and enrollment issues, pediatric research bill","Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",,37650,0,0,2019-10-10T16:04:42.957000-04:00
2340288,f431fe74-360d-47cc-99e5-7e2fb1e25910,Q3,NEOGENOMICS LABORATORIES,401105014,NEOGENOMICS LABORATORIES,2019,third_quarter,MED,"Laboratory Access for Beneficiaries Act (LAB Act) HR 3584
Verifying Accurate Leading-Edge IVCT Development Act (VALID Act), Draft Legislation","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2019-10-10T17:34:24.993000-04:00
2340441,254f2e3d-9891-48ca-8ec0-1d2aac4cda7d,Q3,ISEMAN & ASSOCIATES LLC,401103582,"TICHENOR VENTURES, LLC",2019,third_quarter,MED,Monitoring biotech legislation,"HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2019-10-11T09:52:58.283000-04:00
2340445,55b2a2d4-24cc-4f4f-90ae-e44c4b7cc032,Q3,ISEMAN & ASSOCIATES LLC,401103582,"PILLNURSE, LLC",2019,third_quarter,MED,Medical device funding,"HOUSE OF REPRESENTATIVES,SENATE",22500,,0,0,2019-10-11T09:53:59.897000-04:00
2340541,79c4664c-c74b-4138-94af-527b15d99a6a,Q3,SQUIRE PATTON BOGGS,30906,ALLIANCE FOR BIOSECURITY,2019,third_quarter,MED,Preparedness and response as it relates to Biosecurity.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",100000,,0,0,2019-10-11T11:30:55.720000-04:00
2340787,d8e95bee-2184-4f6b-bb45-9a320da70cfe,Q3,IPOLICY SOLUTIONS,401105127,ASSOCIATION FOR MOLECULAR PATHOLOGY,2019,third_quarter,MED,"No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2019-10-11T15:05:28.917000-04:00
2340794,731c97b8-97d4-410d-be26-af20a7fd9401,Q3,IPOLICY SOLUTIONS,401105127,INVITAE INC.,2019,third_quarter,MED,"No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act","HOUSE OF REPRESENTATIVES,SENATE",58000,,0,0,2019-10-11T15:12:33.817000-04:00
2340831,2fdfbe2e-d932-4914-b941-a7c2cd8b3bb8,Q3,IPOLICY SOLUTIONS,401105127,"SEMA4 (FORMERLY KNOWN AS MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4))",2019,third_quarter,MED,Innovation in precision medicine,"HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2019-10-11T15:24:46.597000-04:00
2340832,ae8ce665-1554-42dd-ad14-1cfa280b96d7,Q3,IPOLICY SOLUTIONS,401105127,GENOMIND INC.,2019,third_quarter,MED,Oversight of pharmacogenomic testing,"HOUSE OF REPRESENTATIVES,SENATE",9500,,0,0,2019-10-11T15:29:47.727000-04:00
2340835,100bea35-9791-49d9-af11-8c8f2ef4addb,Q3,IPOLICY SOLUTIONS,401105127,EVANOSTICS,2019,third_quarter,MED,clinical research on opioid use disorder,Natl Institutes of Health (NIH),,,0,0,2019-10-11T15:35:51.047000-04:00
2340862,af91a2bc-76d4-4bec-abb7-324543d352c7,Q3,MUNK POLICY & LAW,401105075,SOUTHERN METHODIST UNIVERSITY,2019,third_quarter,MED,Traumatic Brain Injury Research,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2019-10-11T16:51:10.500000-04:00
2340920,7ae895fe-8282-4001-a516-896e2a741cba,Q3,CHRISTOPHERSEN INC,401105404,SOCATI,2019,third_quarter,MED,"Safe Banking Act HR1595

cannabis, manufacturing, economic development, consumer issues product safety, food industry/safety/labeling, medical/disease research/clinical labs, small business, agriculture","Administration for Children & Families (ACF),Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2019-10-12T14:18:03.840000-04:00
2340930,174a7e17-c0ff-4d0b-bd92-fbe0a79f929e,Q3,"MOLNLYCKE HEALTH CARE US, LLC",401104898,"MOLNLYCKE HEALTH CARE US, LLC",2019,third_quarter,MED,Pursuance of approval from relevant agencies of a medical pilot program; gathering support from Congressional leaders.,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,80000,0,0,2019-10-13T08:06:19.443000-04:00
2341175,52e97d0a-7232-4a5f-91f3-21b93402cb5a,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE,2019,third_quarter,MED,Public Health Programs for Infectious and Tropical Disease and Anti-Microbial Resistance; NIH Research.,"Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",50000,,0,0,2019-10-14T11:06:21.890000-04:00
2341180,bfccaacc-f7da-49b7-9fde-c46cb7d41e08,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA,2019,third_quarter,MED,Issues related to anti-microbial resistance and neglected tropical diseases; H.R.3460 - End Neglected Tropical Diseases Act.,,10000,,0,0,2019-10-14T11:08:24.187000-04:00
2341201,f43133d4-0dc7-49ef-8e58-c6289e4bb488,Q3,FAEGRE DRINKER BIDDLE & REATH LLP,12631,PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH,2019,third_quarter,MED,H.R. 3460 End Neglected Tropical Diseases Act; COMPETES Act Reauthorization; P.L. 116-22 - Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019; Draft neglected diseases of poverty legislation.,Office of Management & Budget (OMB),20000,,0,0,2019-10-14T11:15:33.273000-04:00
2341504,2486e3e1-1155-4ab6-a2a2-448cdc40a2dc,Q3,THE FERRARO GROUP,401105251,THE ROGOSIN INSTITUTE,2019,third_quarter,MED,"H.R.1224 and S.511, The Living Donor Protection Act
S.1676 and H.R.3912 -- The Chronic Kidney Disease Improvement in Research and Treatment Act of 2019","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2019-10-14T14:42:24.903000-04:00
2341563,d1b08bea-7247-456a-b26d-48d0f5a1309a,Q3,SQUIRE PATTON BOGGS,30906,"IMPACT JOURNALS, LLC",2019,third_quarter,MED,National Library of Medicine publication and archive matters.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2019-10-14T14:57:47.620000-04:00
2341735,325a3f30-f312-401d-9919-21e3f9e5eba3,Q3,RAY C CULVER III,11468,ARKANSAS CHILDREN'S HOSPITAL,2019,third_quarter,MED,Funding for USDA ARS Human Nutrition Research Centers in House and Senate FY20 Agricultural Appropriations bills.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2019-10-14T18:45:03.257000-04:00
2341944,0ad21bb2-99fa-49b4-b2c2-66374835f603,Q3,"EFB ADVOCACY, LLC",401104430,UNITED FOR MEDICAL RESEARCH,2019,third_quarter,MED,Funding Issues Related to the National Institutes of Health,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2019-10-15T10:50:33.623000-04:00
2341971,29618db4-7f73-496d-b9a6-4856d130f8eb,Q3,WINNING STRATEGIES WASHINGTON,50796,I AM ALS,2019,third_quarter,MED,Funding for ALS research in annual Defense and Labor-HHS-Education appropriations bills,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2019-10-15T10:54:41.503000-04:00
2342058,f1ec498e-5223-4d1c-adcc-c26d3063e27c,3T,SQUIRE PATTON BOGGS,30906,"MOLNLYCKE HEALTH CARE US, LLC",2019,third_quarter,MED,Working with congressional leaders to improve pressure ulcer reimbursement and awareness and other hospital acquired conditions.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,1,2019-10-15T11:16:23.590000-04:00
2342306,304b534f-49aa-4dab-a812-b4189aba9a2f,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ENDOCRINE SOCIETY,2019,third_quarter,MED,"Research in Endocrinology, Standardization of Hormone Testing
HR 4378 Continuing Appropriations Act, 2020 and Health Extenders Act of 2019
Special Diabetes Program","Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2019-10-15T12:04:47.353000-04:00
2342327,b70514c2-8879-4d19-a572-aa8956474791,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,AMERICAN SOCIETY OF HEMATOLOGY,2019,third_quarter,MED,Research in hematology,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2019-10-15T12:21:56.150000-04:00
2342338,9df4496c-906a-4702-9bf7-a962c48f47b1,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,NATIONAL HEMOPHILIA FOUNDATION,2019,third_quarter,MED,"Hemophilia research, prevention, surveillance and service programs and issues","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",50000,,0,0,2019-10-15T12:23:58.997000-04:00
2342355,7b010b90-562f-4336-8358-6830712f09da,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,NATIONAL ASSOCIATION OF EPILEPSY CENTERS,2019,third_quarter,MED,Research and public health programs in epilepsy.,"Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",10000,,0,0,2019-10-15T12:28:01.967000-04:00
2342522,24c52fb9-a04c-4682-84e8-5d605939e0a8,Q3,AMERICAN PHYSICAL THERAPY ASSOCIATION,3093,AMERICAN PHYSICAL THERAPY ASSOCIATION,2019,third_quarter,MED,"NIH Rehab issues
APTA role with NIH
Traumatic brain injury research
Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions
NIH Research and Development funding
Physical Therapist role in childhood obesity
Relocate TBI State Grant Program to ACL
NIDILRR - Rehab research
Nomination to NIH Committees
Safety of Children in School (Restraint & Seclusion)","Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Social Security Administration (SSA),Veterans Affairs, Dept of (VA),White House Office",,246000,0,0,2019-10-15T13:46:54.303000-04:00
2342946,a7d86138-9d44-4be9-909d-937a93acf8bb,Q3,"TOWNSEND PUBLIC AFFAIRS, INC",54734,CITY OF PARLIER,2019,third_quarter,MED,health benefits legislation,"HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE",7500,,0,0,2019-10-15T15:27:53.470000-04:00
2343289,245903e5-8dbf-4365-b28c-87f8cf9c9b2e,Q3,THORN RUN PARTNERS,400534596,CONTINUING MEDICAL EDUCATION COALITION,2019,third_quarter,MED,"Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act.
Expressing the sense of Congress on the need to improve and expand training for future physicians on properly treating pain and prescribing opioids, and for other purposes (H.Con.Res.8).
Policies to promote the use of continuing medical education to support greater physician understanding about biosimilars.","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2019-10-15T17:40:07.800000-04:00
2343449,745ea8f4-f16a-4011-b7ed-35ef374be18f,Q3,MCDERMOTT WILL & SCHULTE LLP,24338,MAYO CLINIC,2019,third_quarter,MED,Issues impacting academic medical centers.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2019-10-16T09:08:25.470000-04:00
2343464,7f2aaade-3316-436c-86db-b9eca1824d64,Q3,THORN RUN PARTNERS,400534596,GLAUKOS CORPORATION,2019,third_quarter,MED,Issues related to implementation of the 21st Century Cures Act (P.L.114-255).,HOUSE OF REPRESENTATIVES,50000,,0,0,2019-10-16T09:17:31.040000-04:00
2343505,ccda08d7-f03c-43d3-87db-0c4283e95d69,Q3,THORN RUN PARTNERS,400534596,CYSTIC FIBROSIS FOUNDATION,2019,third_quarter,MED,Supporting Funding for the National Institutes of Health (NIH) research and the Food and Drug Administration that benefits people with cystic fibrosis.,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2019-10-16T09:35:46.760000-04:00
2344089,ec771eec-3c0f-4ea1-b13c-5be9207c63b5,Q3,NATIONAL MULTIPLE SCLEROSIS SOCIETY,69674,NATIONAL MULTIPLE SCLEROSIS SOCIETY,2019,third_quarter,MED,N/A,"HOUSE OF REPRESENTATIVES,SENATE",,91538,0,0,2019-10-16T12:24:17.480000-04:00
2344140,2fcea7e2-ba75-4430-bc02-e553feeb2e2c,Q3,"FEDERAL SOLUTIONS, LLC",311371,MISSISSIPPI STATE UNIVERSITY,2019,third_quarter,MED,Labor/HHS/Education Appropriations: Provisions relating to disease research.,"Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE",50000,,0,0,2019-10-16T12:53:37.523000-04:00
2344182,d915b3d9-38e2-47f3-a43c-3af8afb2a51a,Q3,"DESIMONE CONSULTING, LLC",400931695,PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA),2019,third_quarter,MED,"Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the biopharmaceutical industry.","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2019-10-16T13:10:52.677000-04:00
2344219,79005678-1553-420f-94b5-14c7317a5af4,Q3,AMERICAN SOCIETY FOR CLINICAL PATHOLOGY,3435,AMERICAN SOCIETY FOR CLINICAL PATHOLOGY,2019,third_quarter,MED,Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases,"Agency for Healthcare Research & Quality (AHRQ),Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Veterans Affairs, Dept of (VA),White House Office",,43250,0,0,2019-10-16T13:17:58.700000-04:00
2344361,07684936-fd1e-4441-afd9-e61e51d91fda,Q3,AMERICAN GASTROENTEROLOGICAL ASSOCIATION,59650,AMERICAN GASTROENTEROLOGICAL ASSOCIATION,2019,third_quarter,MED,Lobbied for a $2 billion increase in funding for the NIH. Also lobbied for increased funding for the VA's medical and prosthetic research program as well as increased funding for the DoD's Peer-Reviewed Cancer Research Program.,"HOUSE OF REPRESENTATIVES,SENATE",,80000,0,0,2019-10-16T14:11:56.263000-04:00
2344737,665415d9-9a14-4227-9ccd-7486b5189124,Q3,"FEDERAL ADVOCATES, INC.",308172,CANNDESCENT,2019,third_quarter,MED,USDOJ/DEA approval of cannabis/marijuana research facilities.,"HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE",50000,,0,0,2019-10-16T15:26:13.877000-04:00
2345309,83ce6bc6-c4b4-4eba-834d-4b88f5ae174b,Q3,IMPACT HEALTH POLICY PARTNERS,401104696,ABBOTT LABORATORIES,2019,third_quarter,MED,"Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition.","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2019-10-16T21:11:37.147000-04:00
2345310,17441e0a-10e0-46f9-9bf1-c955f4a3df56,Q3,IMPACT HEALTH POLICY PARTNERS,401104696,HACKENSACK MERIDIAN HEALTH,2019,third_quarter,MED,"Issues related to research funding, NIH and other matters.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2019-10-16T21:24:38.033000-04:00
2345325,d00d0d6d-0d35-4649-9680-932ca5594fe5,Q3,IMPACT HEALTH POLICY PARTNERS,401104696,CHILDREN'S HOSPITAL COLORADO,2019,third_quarter,MED,Issues related to pediatric research and children's hospital graduate medical education.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2019-10-16T21:49:43.243000-04:00
2345384,4466a25f-a3c2-40ca-94b9-440f2e08afff,Q3,"FEDERAL ADVOCATES, INC.",308172,OTHRAM,2019,third_quarter,MED,Educating the Department of Justice on modern DNA sequencing and genomics technology.,"Justice, Dept of (DOJ)",15000,,0,0,2019-10-16T23:11:11.627000-04:00
2345524,abf58617-1c6f-4448-a071-99065450db2b,Q3,BRACEWELL LLP,6837,NATIONAL BRAIN TUMOR SOCIETY,2019,third_quarter,MED,work related to the advancement of the Cancer Drug Coverage Parity Act and PCHETA (H.R. 647),"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2019-10-17T09:01:16.917000-04:00
2345579,771133e9-ea4f-403f-aecf-47739d60a172,Q3,FAEGRE BAKER DANIELS CONSULTING,34158,GLOBAL DOWN SYNDROME FOUNDATION,2019,third_quarter,MED,Support for Down Syndrome research funding.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2019-10-17T09:25:41.187000-04:00
2345584,8c665dd4-22df-4bf0-bdc9-1c14ae1c3fe9,Q3,FAEGRE BAKER DANIELS CONSULTING,34158,MYOTONIC DYSTROPHY FOUNDATION,2019,third_quarter,MED,Increasing funding for Myotonic Dystrophy research; Fiscal Year 2019 Labor and HHS appropriations.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2019-10-17T09:26:43.300000-04:00
2345598,3295e71b-29d5-4927-97b8-8e0c6865dfee,Q3,FAEGRE BAKER DANIELS CONSULTING,34158,"MYRIAD GENETICS, INC.",2019,third_quarter,MED,Draft legislation to regulate clinical labs under CLIA and FDA.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2019-10-17T09:28:46.067000-04:00
2345772,21f3b89f-0e06-4ba3-9f2a-e7a74c1eda33,Q3,"WILLIAMS AND JENSEN, PLLC",41454,GLOBAL DOWN SYNDROME FOUNDATION,2019,third_quarter,MED,Support for down syndrome research funding.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",40000,,0,0,2019-10-17T10:09:34.947000-04:00
2345802,1d8e08a5-839e-4c39-9082-d9fb5eede472,Q3,"WILLIAMS AND JENSEN, PLLC",41454,"SANOFI, U.S.",2019,third_quarter,MED,General education about FDA approval policies and NIH research activities.,"HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2019-10-17T10:20:44.627000-04:00
2345811,fbbe1c95-220b-4caf-97ab-c6355761c4f7,Q3,"WILLIAMS AND JENSEN, PLLC",41454,VERTEX PHARMACEUTICALS INCORPORATED,2019,third_quarter,MED,General education about FDA approval policies and NIH research activities.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2019-10-17T10:21:45.910000-04:00
2345865,d5a1ef3f-7f1d-4a41-9e16-713e3f4bc8b4,Q3,AMERICA'S BLOOD CENTERS,3834,AMERICA'S BLOOD CENTERS,2019,third_quarter,MED,"Value of Blood/Reimbursement
Blood center testing for Babesia
Bacterial risk strategies for platelets","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,20000,0,0,2019-10-17T10:34:07.640000-04:00
2345886,6b3e2c4a-8662-4a95-8f99-e9d9f58ef7d9,Q3,SIDLEY AUSTIN LLP,35230,CORD BLOOD ASSOCIATION,2019,third_quarter,MED,Legislative and Federal agency activities related to the Stem Cell Therapeutic and Research Reauthorization Act of 2015.,"Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),White House Office",20000,,0,0,2019-10-17T10:39:14.520000-04:00
2346223,0b0c83be-5872-47c0-a48f-651d70caaa9e,Q3,"GOVERNMENT COUNSEL, LLC",401105070,"HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS)",2019,third_quarter,MED,The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2018,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2019-10-17T11:32:13.457000-04:00
2346439,6395210c-b715-4e16-a9e6-db41352ebd68,Q3,HACKENSACK MERIDIAN HEALTH,401104109,HACKENSACK MERIDIAN HEALTH,2019,third_quarter,MED,"National Institutes of Health funding 
Behavioral health 
Substance abuse, opioids, and patient data","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,40000,0,0,2019-10-17T12:08:35.490000-04:00
2346523,5e060405-e851-48ec-98f5-bf08e6d2adca,Q3,BRACEWELL LLP,6837,AIR LIQUIDE USA LLC,2019,third_quarter,MED,work related to medical gases,"Bureau of Land Management (BLM),Commerce, Dept of (DOC),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),Internal Revenue Service (IRS),SENATE,Treasury, Dept of",90000,,0,0,2019-10-17T12:19:02.077000-04:00
2346746,f454332b-76f1-4a6a-93ab-ba00a31c481f,Q3,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2019,third_quarter,MED,Support for all federal agencies that fund medical and disease research,"Commerce, Dept of (DOC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE",,50000,0,0,2019-10-17T13:12:16.480000-04:00
2346853,3627a62e-7cce-4bb6-8472-d0448b32f73a,Q3,CAPITOL HILL CONSULTING GROUP,72053,OKLAHOMA STATE UNIVERSITY CENTER FOR HEALTH SCIENCES,2019,third_quarter,MED,Government funding of medical research.,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2019-10-17T13:36:50.573000-04:00
2346945,35c67f9f-de39-4ccd-bbc4-d039c9e1f2d5,Q3,SCHAGRIN ASSOCIATES,34477,GOOD SAMARITAN HOSPITAL,2019,third_quarter,MED,"House, Senate, Labor, Health & Human Services, and Education, and Related Agencies Bill, H.R. 2740
House, Senate, Homeland Security Appropriations Bills, H.R. 3931, S. 2582
House, Senate, Department of Defense Appropriations Bill, H.R. 2968, now in H.R. 2740
Pursuit of grants with Federal agencies
House, Senate Department of Agriculture Appropriations Bill, H.R. 3164, now in H.R. 3055
House, Senate Department of Transportation, Housing and Urban Development Appropriations Bill,
H.R. 3163, now in H.R. 3055
House, Senate Energy and Water Development Appropriations Bill, H.R. 2690, now in H.R. 2740
House, Senate Financial Services Appropriations Bills, H.R. 3351, S. 2524
House, Senate Infrastructure Bills, i.e., H.R. 2741","Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Corporation for Natl & Community Service,Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Energy, Dept of,Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Interior, Dept of (DOI),Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Treasury, Dept of",30000,,0,0,2019-10-17T13:53:21.027000-04:00
2347124,901b56b0-6683-415c-88d0-5a70eb364421,Q3,AMERICAN ACADEMY OF PHYSICAL MEDICINE AND REHABILITATION,400864533,AMERICAN ACADEMY OF PHYSICAL MEDICINE AND REHABILITATION,2019,third_quarter,MED,"Rehab research funding
Expanding rehab research related to neurodisorders, stroke, and MSK","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,10000,0,0,2019-10-17T14:19:22.813000-04:00
2347269,850e356f-a05d-437a-b53f-86e9efa2d4d5,Q3,SQUIRE PATTON BOGGS,30906,THOMAS JEFFERSON UNIVERSITY,2019,third_quarter,MED,"Advancing health system legislative and regulatory issues including: the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program.","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2019-10-17T14:38:07.347000-04:00
2347334,4e06f24a-970d-4c55-bf5f-6509e628f3fd,Q3,UNIVERSITY OF MIAMI,39462,UNIVERSITY OF MIAMI,2019,third_quarter,MED,Fire Fighter Cancer,"Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE",,101500,0,0,2019-10-17T14:46:32.057000-04:00
2347407,ecc71068-b868-4613-ba84-4d66726c0409,Q3,"WILLIAMS AND JENSEN, PLLC",41454,ECRI INSTITUTE,2019,third_quarter,MED,"General education regarding patient safety initiatives, medical product safety, and evidence-based healthcare information to improve patient care.","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2019-10-17T14:55:01.097000-04:00
2347502,2f0cefc5-c0bd-415b-a33c-268bf42903ab,Q3,SQUIRE PATTON BOGGS,30906,UNIVERSITY OF GEORGIA,2019,third_quarter,MED,"Traumatic brain injury research, funding, and outreach opportunities. Research related to emerging and infectious diseases.","Agriculture, Dept of (USDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Science Foundation (NSF),SENATE",40000,,0,0,2019-10-17T15:05:43.933000-04:00
2347533,c81baaad-56b7-45ff-9107-f8586f91d78f,Q3,AMERICAN SOCIETY OF ADDICTION MEDICINE,401104864,AMERICAN SOCIETY OF ADDICTION MEDICINE,2019,third_quarter,MED,"Advocated for FY2020 Labor HHS Appropriations bill - appropriations related to strengthening the addiction services workforce, including full funding of the loan repayment program for the substance use disorder treatment workforce authorized in the SUPPORT Act, the mental and substance use disorders training demonstration program authorized in 21st Century Cures Act, and preventive medicine residency programs; report language regarding national standards for treatment programs

Supported HR 3496 & S 1983 CREATE Opportunities Act - grants to, and cooperative agreements with, state and local governments to develop, implement, or expand medication-assisted treatment for incarcerated individuals who are addicted to opioids.

Supported HR 2569 & S 1365 - Comprehensive Addiction Resources Emergency Act - to provide emergency assistance to States, territories, Tribal nations, and local areas affected by the opioid epidemic and to make financial assistance available to States, territories, Tribal nations, local areas, and public or private nonprofit entities to provide for the development, organization, coordination, and operation of more effective and cost efficient systems for the delivery of essential services to individuals with substance use disorder and their families.  Advocated for additional evidence-based standards.

Supported HR 3414 (and prior versions) - Opioid Workforce Act of 2019 - bill increases the number of residency positions eligible for graduate medical education payments under Medicare for hospitals that have addiction or pain management programs, with an aggregate increase of 1,000 positions over a five-year period.

Supported HR 3165 and S 1737 - Mental Health Parity Compliance Act - strengthen parity in mental health and substance use disorder benefits.  Advocated for its inclusion in the Lower Health Care Costs Act of 2019.

Supported S 873 and HR 1879 - Stabilize Medicaid and CHIP Coverage Act which would provide for 12 months of continuous enrollment in Medicaid and CHIP to ensure better access to care and reduce churn.  This bill is not specific to mental health, but it would provide significant stability to those patients and providers. 

Supported H.R.2062/S. 1012 - To amend the Public Health Service Act to protect the confidentiality of substance use disorder patient records.

Supported H.R.1920 - Medicaid Bump Act - To amend title XIX of the Social Security Act to provide a higher Federal matching rate for increased expenditures under Medicaid for mental and behavioral health services, and for other purposes.

Supported H.R.1329 - Medicaid Reentry Act - This bill allows Medicaid payment for medical services furnished to an incarcerated individual during the 30-day period preceding the individual's release.

Supported S 824/HR 1767 - Excellence in Mental Health and Addiction Treatment Expansion Act This legislation would extend and expand the Certified Community Behavioral Health Clinic (CCBHC) demonstration, which is set to end in mid-2019. 

Supported the Parity Enforcement Act (HR 2848). This legislation would give the U.S. Department of Labor authority to levy civil monetary penalties against health insurers and plan sponsors for parity violations of the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008.

Supported HR 2734/S 1448 -  Safer Prescribing of Controlled Substances Act. The bill calls for mandatory education for practitioners licensed to dispense or conduct research with controlled substances in schedule II, III, IV, or V. The education, which would be required as part of a prescribers DEA licensure registration and renewal, will focus on best practices for pain management and alternative non-opioid therapies for pain, methods for diagnosing and treating a substance use disorder, linking patients to evidence-based treatment for substance use disorder, and tools to manage adherence and diversion of controlled substances, including Prescription Drug Monitoring Programs. 

Advocated for further alignment of Part 2 with HIPAA for purposes of treatment, payment, and health care operations with the Department of Health and Human Services/SAMHSA

Advocated for reduction of barriers to buprenorphine related to treatment of hospitalized patients.

Technical assistance regarding implementation of CMS related provisions in the SUPPORT for Patients and Communities Act

Advocated for clarification/guidance regarding DATA Waiver and education provisions in the SUPPORT for Patients and Communities Act

Supported the Marijuana and Cannabidiol  Research Expansion Act. This legislation would enable the expansion of the scientific research base on marijuana to answer critical questions, such as identifying potential therapeutic effects and possible public health consequences.

Discussions with CMS regarding barriers to accessing addiction care in Medicare and Medicaid and suggestions for improvements.  Discussions/comments regarding FY20 Medicare Physician Fee Schedule, particularly around OTP payment bundle and OUD demonstration payment codes 

Advocated for filing of the Medication Access and Training Expansion Act which would require every DEA controlled substance prescriber to satisfy an addiction medicine education requirement

Submitted a letter in response to a request for comments from the Food and Drug Administration regarding data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds. ASAMs letter stressed the importance of conducting additional research on cannabis.

Supported the Medical Marijuana Research Act of 2019, which would reduce many of the burdensome barriers researchers face when conducting legitimate scientific research involving cannabis. The bill would ensure that a supply of cannabis is continuously available to researchers, streamline various cannabis related application processes that run through the Department of Justice, and require the Department of Health and Human Services to conduct a review of existing research on cannabis. 

Issued a conditional endorsement of The Mainstreaming Addiction Treatment Act, which is contingent upon the elimination of DEA regulations on medications in Schedules III-V that are based on the prescribing intent to treat addiction and a requirement that all DEA controlled substance prescribers complete medical education on addiction. 

Supported the Expanding Findings for Federal Opioid Research and Treatment (EFFORT) Act, sponsored by Representative Jennifer Wexton (D-VA) and Representative Jim Baird (R-IN). The bill would direct the National Science Foundation to support research on opioid use disorder.

Supported the Humane Correctional Health Care Act , H.R. 4141/S. 2305, which would repeal the Medicaid Inmate Exclusion. The exclusion strips health coverage from Medicaid enrollees who are involved in the criminal justice system. 

Provided comments to SAMHSA's issuance of notices of proposed rulemaking (NPRM), Coordinating Care and Information Sharing in the Treatment of Substance Use Disorders, which would, among other things, modify and modernize 42 CFR Part 2, the regulations that govern confidentiality of drug and alcohol treatment and prevention records. The changes would strengthen the ability of healthcare providers to coordinate care for patients suffering from substance use disorder.

Replied to the Request for Information: Ensuring Patient Access and Effective Drug Enforcement. In its comments, ASAM urged the DEA to investigate whether some of its policies were unintentionally decreasing access to buprenorphine. The letter also discussed opportunities for improved education of the medical community, and possible enhancements to state PDMPs.

Supported H.R. 3925, the Reducing Barriers to Substance Use Treatment Act, introduced by Representatives Paul Tonko (D-NY) and David McKinley (R-VA). The bill would prohibit state Medicaid programs, beginning in October 1, 2020, and ending September 30, 2025, from imposing prior authorizations or other types of utilization control policies or procedures on medications approved to treat OUD, including, with respect to the provision of those medications, counseling services and behavioral therapy.

Support the Stopping Appealing Flavors in E-Cigarettes for Kids Act (SAFE Kids Act), introduced by Senator Dick Durbin and Senator Lisa Murkowski (S. 655) and Representative Diana DeGette and Representative Jamie Raskin (H.R. 1498).  The bill would prohibit flavors in e-cigarettes unless the manufacturer demonstrates that a flavor will help with smoking cessation, not increase youth initiation, and not increase the risk of harm to the user. It furthermore prohibits use of flavors in other non-cigarette tobacco products, such as cigars and smokeless tobacco.  

Opposed the Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019, which would prohibit FDA from promulgating any public health protections related to what the cigar industry calls traditional large and premium cigars. Even the most basic Food and Drug Administration (FDA) requirements like ingredient disclosure and warning labels as well as enforcement of youth access laws would not apply to these products.

Submitted comments on the 2020 Medicare Physician Fee Schedule Proposed Rule. In its comments, ASAM applauded the introduction of two bundled payment structures, one for outpatient treatment of OUD and one for OTPs. However, it also noted that the proposed reimbursement rates were significantly lower than necessary to expand access to MAT.

Supported the Reversing the Youth Tobacco Epidemic Act of 2019 (HR 2339) which would, among other things, amend the Federal Food, Drug, and Cosmetic Act with respect to the sale and marketing of tobacco products","Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)",,60000,0,0,2019-10-17T15:08:54.327000-04:00
2347652,7c68ba5f-68ed-4b6b-8b12-95b5b78eaf36,Q3,UNIVERSITY OF SOUTH FLORIDA,401081033,UNIVERSITY OF SOUTH FLORIDA,2019,third_quarter,MED,"Support for NIH research programs;
Support for medical education programs.","HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2019-10-17T15:25:38.700000-04:00
2347797,9e6dc4a3-22f3-4ae2-9998-cf36a536818c,Q3,ASSOCIATION OF AMERICAN MEDICAL COLLEGES,4493,ASSOCIATION OF AMERICAN MEDICAL COLLEGES,2019,third_quarter,MED,"P.L. 114-255, 21st Century Cures Act, Division A
Issue: Support implementation of 21st Century Cures Act, including the Innovation Fund, increased funding for medical research, reducing administrative and regulatory burden on scientists and research institutions, and supporting young investigators.","Agency for Healthcare Research & Quality (AHRQ),Bureau of Citizenship & Immigration Services (BCIS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Education, Dept of,Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Natl Science Foundation (NSF),Office of Management & Budget (OMB),Office of Natl Drug Control Policy (NDCP),Office of Science & Technology Policy (OSTP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Treasury, Dept of,Veterans Affairs, Dept of (VA),White House Office",,1127000,0,0,2019-10-17T15:39:24.307000-04:00
2347813,524d6a4a-89f9-4b61-8a94-542c315a797c,Q3,STEWART AND STEWART,36776,GOOD SAMARITAN HOSPITAL,2019,third_quarter,MED,"House, Senate, Labor, Health & Human Services, and Education, and Related Agencies Bill, H.R. 2740
House, Senate, Homeland Security Appropriations Bills, H.R. 3931, S. 2582
House, Senate, Department of Defense Appropriations Bill, H.R. 2968, now in H.R. 2740
House, Senate, Department of Interior Appropriations Bill, H.R. 3052, now in H.R. 3055
Pursuit of grants with Federal agencies
House, Senate Department of Agriculture Appropriations Bill, H.R. 3164, now in H.R. 3055
House, Senate Department of Transportation, Housing and Urban Development Appropriations Bill,
H.R. 3163, now in H.R. 3055
House, Senate Energy and Water Development Appropriations Bill, H.R. 2690, now in H.R. 2740
House, Senate Financial Services Appropriations Bills, H.R. 3351, S. 2524","Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Corporation for Natl & Community Service,Defense, Dept of (DOD),Energy, Dept of,Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Interior, Dept of (DOI),Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Treasury, Dept of",,,0,0,2019-10-17T15:40:28.370000-04:00
2348057,4f486e59-c2f8-426c-993c-dee67eeafced,Q3,VANDERBILT UNIVERSITY,39861,VANDERBILT UNIVERSITY,2019,third_quarter,MED,"H.R. 2740/S. xxxx - the FY 20 Labor-HHS-Education Appropriations Act - provisions related to funding for the National Institutes of Health 

General issues related to the outlook for NIH funding FY 20","HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of",,20000,0,0,2019-10-17T16:10:44.427000-04:00
2348151,c3cfeb69-067a-4b67-a7e1-5bf6c1781f55,Q3,STANFORD UNIVERSITY,36492,STANFORD UNIVERSITY,2019,third_quarter,MED,"Health Professions Programs

Graduate Medical Education Funding

Pediatric GME Programs","Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE",,90000,0,0,2019-10-17T16:32:18.617000-04:00
2348203,8acbf254-f557-4466-ad23-b54fad208ed1,3A,SCHAGRIN ASSOCIATES,34477,GOOD SAMARITAN HOSPITAL,2019,third_quarter,MED,"House, Senate, Labor, Health & Human Services, and Education, and Related Agencies Bill, H.R. 2740
House, Senate, Homeland Security Appropriations Bills, H.R. 3931, S. 2582
House, Senate, Department of Defense Appropriations Bill, H.R. 2968, now in H.R. 2740
Pursuit of grants with Federal agencies
House, Senate Department of Agriculture Appropriations Bill, H.R. 3164, now in H.R. 3055
House, Senate Department of Transportation, Housing and Urban Development Appropriations Bill,
H.R. 3163, now in H.R. 3055
House, Senate Energy and Water Development Appropriations Bill, H.R. 2690, now in H.R. 2740
House, Senate Financial Services Appropriations Bills, H.R. 3351, S. 2524
House, Senate Infrastructure Bills, i.e., H.R. 2741","Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Corporation for Natl & Community Service,Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Energy, Dept of,Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Interior, Dept of (DOI),Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Treasury, Dept of",10000,,0,0,2019-10-17T16:43:35.940000-04:00
2348367,0b3ee0ca-18bf-4951-873d-e3741002ee86,Q3,MCDERMOTT+ LLC,401103287,COALITION FOR 21ST CENTURY MEDICINE,2019,third_quarter,MED,Issues concerning regulation of laboratory-developed tests.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",40000,,0,0,2019-10-17T17:14:25.860000-04:00
2348397,2d980a0f-6203-41a5-ad2f-850c94af2b01,Q3,"THE CORMAC GROUP, LLC",66773,KESSLER FOUNDATION,2019,third_quarter,MED,"Appropriations, DOD, TBI research, Veterans Issues","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2019-10-17T17:19:34.943000-04:00
2348697,38438908-6cb2-4ea2-8312-62b868951e21,Q3,"THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA)",2970,"THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA)",2019,third_quarter,MED,"HR 2740 - Labor, HHS, Education, Defense, State, Foreign Operations and Energy and Water development Appropriations Act, 2020: Support for Heart and Lung Research.  Support for Increased funding for SAMHSA and HRSA programs.

HR 2968 - Department of Defense Appropriations Act, 2020:  Support for designating a stand-alone arthritis program within the Congressionally Directed Medical Research Program (CDMRP) at the Department of Defense, funded at $20 million for FY 2020.","Education, Dept of,HOUSE OF REPRESENTATIVES,SENATE",,170000,0,0,2019-10-17T18:40:31.423000-04:00
2348712,18b1e252-d944-4041-9446-20cca339b379,3T,STEWART AND STEWART,36776,GOOD SAMARITAN HOSPITAL,2019,third_quarter,MED,"House, Senate, Labor, Health & Human Services, and Education, and Related Agencies Bill, H.R. 2740
House, Senate, Homeland Security Appropriations Bills, H.R. 3931, S. 2582
House, Senate, Department of Defense Appropriations Bill, H.R. 2968, now in H.R. 2740
House, Senate, Department of Interior Appropriations Bill, H.R. 3052, now in H.R. 3055
Pursuit of grants with Federal agencies
House, Senate Department of Agriculture Appropriations Bill, H.R. 3164, now in H.R. 3055
House, Senate Department of Transportation, Housing and Urban Development Appropriations Bill,
H.R. 3163, now in H.R. 3055
House, Senate Energy and Water Development Appropriations Bill, H.R. 2690, now in H.R. 2740
House, Senate Financial Services Appropriations Bills, H.R. 3351, S. 2524","Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Corporation for Natl & Community Service,Defense, Dept of (DOD),Energy, Dept of,Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Interior, Dept of (DOI),Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Treasury, Dept of",20000,,0,1,2019-10-17T18:59:37.033000-04:00
2348996,0fbc5430-5d6a-46f3-b19a-b1f51b7dddf2,Q3,ACUITY STRATEGIC PARTNERS LLC,401105363,"AMICUS THERAPEUTICS, INC.",2019,third_quarter,MED,Reimbursement for rare disease patient care,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2019-10-18T06:38:39.020000-04:00
2349000,0466031e-d8cb-4b66-9ef1-055dd0eb6523,Q3,COMMONWEALTH POLICY SOLUTIONS,401105004,TRISALUS LIFE SCIENCES,2019,third_quarter,MED,"Medical device development for oncology, drug delivery for oncology","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2019-10-18T06:39:39.847000-04:00
2349003,fb9e00ea-123e-43d7-9044-a5e01e3bf63a,Q3,COMMONWEALTH POLICY SOLUTIONS,401105004,RARE ACCESS ACTION PROJECT,2019,third_quarter,MED,Reimbursement for rare disease patient care,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2019-10-18T06:40:40.537000-04:00
2349124,4977135e-e1f1-44bb-a971-ba78bc73c007,Q3,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION,2019,third_quarter,MED,"Research opportunities at the Department of Defense and the Centers for Disease Control
HR 2968; S 2474 Department of Defense Appropriations Act 2020
HR 2740, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020
Defense Medical Research, NIH funding","HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",10000,,0,0,2019-10-18T09:02:32.443000-04:00